Jasmien Cornillie - Publications

Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma.

Journal: International journal of molecular sciences

Published: May 31, 2022

Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts.

Journal: BMC cancer

Published: March 20, 2019

Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 02, 2019

Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral Center.

Journal: Oncology research and treatment

Published: January 01, 2019

Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing.

Journal: Molecular cancer therapeutics

Published: September 13, 2018

PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors.

Journal: Clinical and experimental medicine

Published: July 05, 2018

Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 13, 2018

Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center.

Journal: Oncology research and treatment

Published: October 04, 2017

In Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft Models.

Journal: Molecular cancer therapeutics

Published: December 05, 2016

Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy.

Journal: Oncology research and treatment

Published: November 03, 2016

Biology and management of clear cell sarcoma: state of the art and future perspectives.

Journal: Expert review of anticancer therapy

Published: June 03, 2016

Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different KIT Mutations.

Journal: Molecular cancer therapeutics

Published: April 11, 2016